Home > Income Statement > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Revenue

    Back to Income Statement
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹48,497 Cr₹43,886 Cr₹38,654 Cr₹33,498 Cr₹32,838 Cr

What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?

The latest Revenue ratio of SUN PHARMACEUTICAL INDUSTRIES is ₹48,497 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹48,497 Cr
Mar2024₹43,886 Cr
Mar2023₹38,654 Cr
Mar2022₹33,498 Cr
Mar2021₹32,838 Cr

How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years Revenue % Change
Mar2025 ₹48,497 Cr
10.51
Mar2024 ₹43,886 Cr
13.53
Mar2023 ₹38,654 Cr
15.39
Mar2022 ₹33,498 Cr
2.01
Mar2021 ₹32,838 Cr -

Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹397,012.2 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics
MANKIND PHARMA ₹85,816.7 Cr 3% -3.9% -15.4% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-2.3%

-8.5%

-3%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses